Is IVF Really Necessary? Understanding Teratozoospermia, Male Infertility and the Importance of Choosing the Right Fertility Treatment
Saira Health Care Presents an Important Educational Discussion by Dr. Nizamuddin Qasmi on Why IVF Should Not Automatically Be the First Choice, Why IVF Recommendations Are Increasingly Common, the Truth About Abnormal Sperm Morphology, and the Importance of Proper Male Infertility Evaluation.
Date: 16 October 2026
Category: Male Infertility | IVF Awareness | Reproductive Health
Presented by: Dr. Nizamuddin Qasmi, Founder & Chief Physician, Saira Health Care
Saira Health Care Raises Awareness About Important Decisions Before IVF Treatment
In vitro fertilization (IVF) has transformed reproductive medicine and helped many couples achieve their dream of parenthood. With significant advancements in assisted reproductive technology, IVF and related procedures have become increasingly familiar to couples experiencing infertility.
However, an important question deserves attention:
Is IVF necessary for every couple struggling to conceive, or should potentially treatable causes of infertility be investigated before proceeding with assisted reproductive treatment?
This question is especially relevant when a couple receives an abnormal semen analysis report and is advised to consider IVF or intracytoplasmic sperm injection (ICSI).
At Saira Health Care, Dr. Nizamuddin Qasmi is addressing these concerns through an educational video titled "Watch This Before IVF."
The discussion aims to improve public awareness about IVF recommendations, sperm morphology abnormalities, teratozoospermia, semen analysis, and the importance of evaluating male reproductive health before choosing a fertility treatment.
The objective is not to discourage IVF or question its established medical value. Instead, it is to encourage accurate diagnosis, informed consent, appropriate investigation, and individualized treatment decisions.
The central message is simple: IVF may be an excellent treatment when indicated, but no couple should feel pressured into starting it without understanding the diagnosis, available alternatives, expected benefits, and potential risks.
What Is IVF and How Does It Work?
IVF, or In Vitro Fertilization, is an assisted reproductive technology in which fertilization takes place outside the human body under controlled laboratory conditions.
The procedure generally involves stimulating the ovaries to develop multiple follicles, retrieving mature eggs, combining eggs and sperm in a laboratory, monitoring embryo development, and transferring a selected embryo into the uterus.
Additional embryos suitable for freezing may be preserved for future use.
IVF is a sophisticated medical treatment requiring reproductive specialists, trained embryologists, specialized laboratories, medications, and careful monitoring.
It can be particularly helpful when natural fertilization is difficult or when other appropriate treatment approaches have not achieved pregnancy.
What Is the Difference Between IVF and ICSI?
Although these terms are often used together, they describe different laboratory procedures.
Conventional IVF: Prepared sperm are placed with an egg in laboratory conditions, allowing fertilization to occur.
ICSI (Intracytoplasmic Sperm Injection): An embryologist injects a single selected sperm directly into an egg.
ICSI may be particularly useful in certain cases of significant male infertility or previous fertilization failure.
However, ICSI should not automatically be considered necessary for every IVF cycle. Its use should depend on the clinical situation and available evidence.
Why IVF Should Not Automatically Be the First Choice for Every Couple
Infertility is not a single disease with one universal treatment.
Different couples experience difficulty conceiving for different reasons.
Some conditions may respond to medical management, changes in medication, targeted surgery, ovulation-related treatment, or carefully selected assisted reproduction approaches.
Other cases may require IVF or ICSI without unnecessary delay.
Before recommending treatment, healthcare professionals should consider the cause of infertility, the couple's ages, the duration of infertility, relevant laboratory findings, reproductive history, and personal preferences.
1. Some Causes of Infertility Are Potentially Treatable
Certain reproductive conditions can be identified and managed after appropriate investigation.
For example, selected cases of hormonal dysfunction, ovulatory disorders, ejaculation difficulties, or clinically significant varicocele may have specific treatment options.
Addressing these conditions can sometimes improve reproductive outcomes.
However, improvement cannot be guaranteed, and treatment may not eliminate the need for IVF.
2. Male Infertility Requires Proper Evaluation
A semen analysis provides important information, but it does not identify every possible cause of infertility.
A comprehensive male evaluation may reveal abnormalities that were not apparent from the initial report.
3. An Abnormal Sperm Parameter Does Not Automatically Mean IVF Is Necessary
Low sperm count, reduced sperm motility, or abnormal sperm morphology may influence fertility, but the significance depends on the complete clinical picture.
A single abnormal parameter should not be treated as a definitive diagnosis of infertility.
4. IVF Is Not the Only Fertility Management Option
Depending on the diagnosis, suitable options may include expectant management, treatment of specific medical conditions, selected surgical interventions, ovulation induction, IUI, IVF, or IVF with ICSI.
Not every alternative is effective for every condition.
5. IVF Requires Financial, Physical and Emotional Preparation
IVF may involve significant expenditure, repeated clinical visits, hormonal stimulation, procedures and emotional uncertainty.
The possibility of ovarian hyperstimulation, procedural complications, unsuccessful treatment cycles, and other risks should be discussed.
A clear understanding of costs and realistic success probabilities helps couples prepare for treatment.
When IVF May Be the Best First Treatment
Importantly, IVF should not be postponed merely to try alternatives that have little realistic chance of success.
For example, IVF may be considered early when both fallopian tubes are severely damaged, there is significant male-factor infertility, particular reproductive conditions limit natural conception, or age-related fertility considerations make waiting undesirable.
Current fertility guidelines also recognize IVF as an appropriate treatment for selected cases of prolonged unexplained infertility.
The goal is not to avoid IVF at all costs. The goal is to choose the treatment most likely to help the individual couple within an appropriate timeframe.
Why Is IVF Being Recommended So Frequently Nowadays?
An important topic in Dr. Nizamuddin Qasmi's educational discussion is the increasing visibility and frequent consideration of IVF.
Several factors may contribute to this perception.
Advances in Reproductive Technology
Modern fertility laboratories, improved embryo culture systems, cryopreservation techniques and advances in reproductive medicine have expanded the circumstances in which IVF can be considered.
Greater Public Awareness
Couples today are more likely to encounter information about IVF through hospitals, specialist clinics, websites, social media, and digital advertisements.
This increased visibility can create the impression that IVF is the standard solution for every fertility problem.
Delayed Parenthood
Some couples begin planning pregnancy at later reproductive ages.
Female age is an important determinant of reproductive potential, and delays may influence which treatments are appropriate.
In selected situations, specialists may recommend IVF sooner because time is an important clinical factor.
Increasing Access to Fertility Services
The expansion of fertility clinics and assisted reproductive services has made IVF more accessible to people who previously had limited treatment opportunities.
The Search for Faster Results
Couples facing prolonged infertility may prefer an approach offering a greater chance of conception within a shorter period, even if it is more invasive or expensive.
For some, IVF is a medically reasonable choice.
Commercial Promotion and Informed Decision-Making
IVF is also a healthcare service offered in a competitive medical environment.
Advertising and promotional messages may emphasize successful outcomes without always communicating the limitations, costs, or possibility of unsuccessful cycles.
However, the frequency of IVF advertising does not establish that IVF is being unnecessarily recommended by all fertility specialists.
Treatment recommendations should be judged individually against recognized clinical indications.
Patients have the right to ask why IVF is recommended, whether the diagnosis is complete, and what other medically appropriate choices are available.
The Truth About Teratozoospermia: Does Abnormal Sperm Morphology Mean IVF Is Necessary?
One of the most important parts of the discussion focuses on teratozoospermia, sometimes called teratospermia.
The condition refers to a reduced proportion of sperm cells with normal morphology, or shape.
Many men become extremely worried after receiving reports showing 1%, 2%, or 3% normal sperm morphology.
Some fear that natural pregnancy is impossible or that IVF and ICSI are their only options.
Understanding the actual significance of these results is essential.
What Is Sperm Morphology?
Sperm morphology describes the microscopic appearance and structural characteristics of sperm cells.
A typical sperm has three major components:
The head: Contains the genetic material and structures important for fertilization.
The midpiece: Contains structures involved in supplying energy for sperm movement.
The tail: Helps the sperm move through fluid.
During semen analysis, laboratory professionals examine sperm shape according to established morphological criteria.
Sperm may demonstrate abnormalities involving the head, midpiece, tail, or multiple structures.
What Is Normal Sperm Morphology?
According to the World Health Organization's Sixth Edition semen laboratory reference data, approximately 4% normal forms represents the lower reference value when sperm morphology is assessed using strict criteria.
This figure is often misunderstood.
A report showing 4% normal morphology does not mean that 96% of sperm are incapable of fertilization.
Similarly, 1% or 2% normal morphology does not automatically establish complete infertility.
These values describe laboratory observations within standardized assessment methods, not absolute boundaries between fertility and infertility.
Understanding Sperm Morphology Results
| Normal Morphology Result | General Interpretation |
|---|
| 4% or higher | At or above the WHO lower reference value |
| 3% | Below the reference value |
| 2% | Below the reference value |
| 1% | Below the reference value |
| 0% | No normally shaped sperm identified in the examined sample |
These results require consideration of sperm count, motility, sample quality, female reproductive factors, and medical history.
A report of 0% normal morphology does not always mean that no sperm are capable of fertilization. However, specific severe structural abnormalities may require specialized assessment.
Can Natural Pregnancy Occur With Teratozoospermia?
Yes, natural pregnancy may occur in some couples where the male partner has teratozoospermia.
The possibility depends on factors such as:
- Sperm concentration and total sperm number
- Progressive sperm motility
- The type and extent of morphology abnormalities
- Female partner's age and reproductive health
- Duration of infertility
- Presence of additional reproductive conditions
When abnormal morphology is the only abnormal semen parameter, its relationship with fertility can be less straightforward than many patients expect.
Isolated teratozoospermia is not, by itself, an automatic indication for IVF or ICSI.
However, certain specific morphology defects, including some severe genetic or structural sperm abnormalities, may have a much greater effect on fertilization and require expert evaluation.
Does Teratozoospermia Always Require ICSI?
No.
ICSI may be appropriate when there are significant sperm-related fertilization difficulties, previous fertilization failure, or certain severe sperm abnormalities.
However, routinely recommending ICSI solely because the morphology percentage is below 4% may not always be justified.
A complete fertility assessment is necessary before determining whether natural conception, IUI, conventional IVF, or IVF with ICSI is suitable.
This is an important distinction for patients who are considering expensive or invasive fertility treatment based on one laboratory result.
Male Infertility: Why the Male Partner Should Never Be Overlooked
Infertility is often mistakenly considered primarily a female reproductive issue.
In reality, male reproductive factors contribute to a substantial proportion of infertility cases.
Proper evaluation should involve both partners.
Male infertility may arise from abnormalities affecting sperm production, reproductive hormones, sperm transport, ejaculation, or sperm function.
A man's general health, previous illnesses, surgical history, medications, and lifestyle may also influence reproductive potential.
Common Male Infertility Conditions
1. Oligozoospermia – Low Sperm Count
Oligozoospermia refers to sperm concentration below the applicable laboratory reference value.
Potential contributing factors include varicocele, hormonal abnormalities, genetic conditions, medication effects, and testicular disorders.
The degree of sperm reduction and associated abnormalities influence treatment decisions.
2. Asthenozoospermia – Reduced Sperm Motility
Asthenozoospermia means that sperm movement is below the relevant reference range.
Sperm motility is important because sperm must move effectively through the reproductive tract.
Reduced motility may occur alongside low sperm concentration or other abnormalities.
3. Teratozoospermia – Abnormal Sperm Morphology
Teratozoospermia describes a reduced proportion of sperm with normal shape.
Its clinical significance must be interpreted alongside the complete semen profile.
4. Azoospermia – Absence of Sperm in Semen
Azoospermia means that sperm are not identified in semen following appropriate laboratory assessment.
Possible causes include obstruction of the reproductive tract or impaired sperm production.
Some cases may be treatable, while others require reproductive technologies or specialized sperm retrieval.
Azoospermia requires timely evaluation and should never be managed by assuming that one medicine can resolve every case.
5. Varicocele
Varicocele involves abnormal enlargement of veins around the testicle.
In selected men, a clinically significant varicocele may contribute to impaired sperm production and abnormal semen parameters.
Treatment can be considered after evaluating clinical findings, semen results, female partner factors, and reproductive goals.
Not every varicocele requires surgery.
6. Hormonal Causes of Male Infertility
Sperm production is influenced by hormones including follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone.
Some endocrine disorders can impair sperm production.
Appropriate treatment depends on identifying the actual hormonal problem.
Importantly, testosterone replacement therapy and anabolic steroids can suppress sperm production and should not be used indiscriminately in men who wish to conceive.
7. Genetic and Testicular Conditions
Some cases of severe sperm deficiency may be associated with genetic abnormalities, previous testicular injury, undescended testes, or impaired testicular development.
Specialized investigations may be necessary.
Understanding Semen Analysis Before Choosing IVF
Semen analysis is an important initial investigation of male reproductive health.
However, interpreting sperm count alone is insufficient.
International reference values published by the WHO provide standardized guidance for laboratory assessment.
WHO Semen Analysis Reference Values
| Parameter | Lower Reference Value |
|---|
| Semen volume | 1.4 mL |
| Sperm concentration | 16 million/mL |
| Total sperm number | 39 million per ejaculate |
| Total motility | 42% |
| Progressive motility | 30% |
| Normal sperm morphology | 4% |
| Sperm vitality | 54% |
These values are derived from a reference population of men whose partners conceived naturally.
They do not function as definitive cutoffs for fertility or infertility.
A complete reproductive assessment is more informative than any single laboratory number.
Why a Repeat Semen Analysis May Be Necessary
Semen parameters naturally vary between samples.
Recent fever, illness, abstinence duration, collection conditions, and other factors may influence results.
If the first report is abnormal, a repeat semen analysis may be recommended.
The timing depends on the severity of the abnormality. In many circumstances, repeat testing after approximately three months can be useful, while severe abnormalities such as azoospermia should prompt more urgent confirmation.
Clinical decisions should not be based unnecessarily on an unreliable or improperly collected sample.
What Tests Should Be Considered Before IVF?
There is no universal panel of investigations suitable for every infertile couple.
Testing should be guided by medical history, clinical examination, and individual reproductive factors.
Evaluation of the Male Partner
A male reproductive assessment may include:
- Detailed medical and reproductive history
- Semen analysis and repeat testing when indicated
- Physical examination of the testes and scrotum
- Assessment for clinical varicocele
- Hormonal investigations such as FSH, LH, and testosterone when indicated
- Selected genetic testing in appropriate cases of severe sperm deficiency
- Scrotal ultrasound or other investigations when clinically justified
Not every patient requires routine sperm DNA fragmentation testing, extensive genetic investigations, or additional expensive laboratory tests.
Evaluation of the Female Partner
Female reproductive evaluation may include assessment of:
- Age and reproductive history
- Ovulation and menstrual cycle patterns
- Ovarian reserve where relevant to treatment planning
- Fallopian tube patency
- Uterine and pelvic abnormalities
- Endometriosis or other suspected reproductive conditions
- Previous pregnancies, miscarriages, or fertility treatments
The purpose of investigating both partners is to determine which reproductive factors are responsible and which treatments are likely to be effective.
Are There Alternatives to IVF?
There may be, depending on the diagnosis.
Expectant Management
In selected couples with favourable reproductive circumstances, continued attempts at natural conception for an appropriate period may be reasonable.
This approach becomes less suitable when reproductive age, severe infertility factors, or prolonged infertility make delay undesirable.
Treatment of Identified Medical Conditions
Specific hormonal disorders, selected ovulation problems, medication-related fertility suppression, or other diagnosed conditions may have established treatment approaches.
Varicocele Treatment
Surgical or radiological treatment may be considered for selected patients with clinically significant varicocele and impaired fertility.
Benefits, uncertainty, recovery time, and the female partner's reproductive situation must be considered.
Intrauterine Insemination (IUI)
IUI involves placing prepared sperm into the uterus around the time of ovulation.
It may be considered for selected couples depending on semen parameters, tubal health, age, and other fertility factors.
IUI is not appropriate for every cause of infertility and may be less effective in some situations than IVF.
IVF and ICSI
IVF or IVF with ICSI may be the most suitable option for some couples, particularly where significant reproductive barriers exist or other appropriate approaches have failed.
The decision should reflect clinical evidence rather than a fixed sequence applied to everyone.
Why Timing Matters
The available treatment options must be considered alongside the couple's reproductive timeline.
For example, prolonged attempts to improve mildly abnormal sperm morphology through unproven treatments could lead to unnecessary delays in a couple with advanced reproductive age.
Therefore, careful selection of treatment is more important than simply choosing the least invasive or most technologically advanced option.
Unani Medicine and Supportive Reproductive Healthcare
Unani medicine has a longstanding history as a traditional healthcare system, emphasizing individual health characteristics, diet, lifestyle, and selected therapeutic preparations.
At Saira Health Care, patient education and individualized supportive care are important components of its approach to sexual and reproductive health.
Lifestyle guidance, nutritional assessment, general health improvement, and traditional healthcare practices may be considered according to the patient's medical circumstances.
However, the effectiveness of individual Unani formulations for reversing male infertility, correcting sperm morphology, or avoiding IVF has not been conclusively established for many treatments.
Traditional medicine should not be described as a guaranteed alternative to IVF or ICSI.
No herbal medicine or supplement should be presented as capable of curing every type of azoospermia, teratozoospermia, or other infertility disorder.
Couples should seek appropriate specialist evaluation and should not delay medically necessary fertility treatment while pursuing unverified claims.
Responsible reproductive healthcare involves investigating the underlying condition and selecting treatments with a realistic possibility of benefit.
Important Questions Every Couple Should Ask Before Starting IVF
Before beginning IVF, couples should feel comfortable discussing the following questions with their fertility specialist:
1. What is our actual infertility diagnosis?
Understanding whether infertility involves male factors, female factors, combined factors, or remains unexplained is important.
2. Have both partners undergone appropriate evaluation?
A complete assessment can identify conditions relevant to treatment decisions.
3. Why is IVF being recommended for us?
The specialist should explain the particular medical indication.
4. Are other treatment options appropriate?
Patients should understand the possible benefits and limitations of alternatives.
5. Is ICSI necessary, or would conventional IVF be suitable?
ICSI is not automatically required for every couple undergoing IVF.
6. How does our age affect the decision?
The female partner's age and ovarian reserve can influence treatment timing and expected success.
7. What are our realistic chances of having a live birth?
Success estimates should be individualized and should distinguish pregnancy rates from live-birth rates.
8. What are the treatment risks and possible complications?
These should be explained before the procedure.
9. What will the total treatment cost include?
Couples should ask about medication costs, laboratory procedures, embryo freezing, storage, additional services, and possible future cycles.
10. Can we obtain a second medical opinion?
A second opinion may be helpful when treatment recommendations are unclear or when couples want reassurance before proceeding.
These questions encourage better communication and help patients participate actively in their healthcare decisions.
Dr. Nizamuddin Qasmi's Message on IVF and Male Infertility Awareness
Through the educational topic "Watch This Before IVF," Dr. Nizamuddin Qasmi seeks to promote a better understanding of male infertility and reproductive treatment choices.
The discussion emphasizes that abnormal sperm morphology, low sperm count, and other semen abnormalities require thoughtful interpretation rather than assumptions based on isolated figures.
It also highlights the importance of accurate diagnosis, assessment of both partners, and the selection of treatment according to the medical circumstances of each couple.
IVF and ICSI remain valuable technologies that can provide important opportunities for many patients.
At the same time, identifying potentially treatable infertility factors and avoiding unnecessary procedures are essential elements of responsible reproductive healthcare.
The broader message is to encourage couples to become informed participants in their treatment decisions.
About Dr. Nizamuddin Qasmi
Founder & Chief Physician – Saira Health Care
Focused Practice: Sexual Disorders & Infertility
Qualifications and Additional Training:
- BUMS – Hamdard University, Delhi
- MD
- CGO
- Certificate in Infertility – MGBIMS, Delhi
- Certificate in Urology – London, United Kingdom
- Masters in Male Infertility – Healthpro
- Integrated Sexual & Reproductive Health – UNFPA
Through clinical consultation and public health education, Dr. Qasmi aims to increase awareness about sexual disorders, male fertility, reproductive investigations, and the importance of appropriate medical advice.
Frequently Asked Questions About IVF, Teratozoospermia and Male Infertility
1. Is IVF necessary for every infertile couple?
No. The appropriate treatment depends on the cause of infertility, reproductive age, medical history, duration of infertility, and other clinical factors.
2. Can a couple achieve natural pregnancy with 2% sperm morphology?
Natural pregnancy is possible in some couples with 2% normal sperm morphology. The result must be interpreted alongside other semen parameters and the female partner's reproductive health.
3. Does 1% normal sperm morphology mean IVF is compulsory?
No. One percent normal morphology is below the WHO lower reference value, but it does not independently establish that IVF or ICSI is mandatory.
4. Is teratozoospermia the same as azoospermia?
No. Teratozoospermia refers to reduced normal sperm morphology, while azoospermia means sperm are not found in the semen after appropriate laboratory examination.
5. Can sperm morphology improve?
Morphology results may vary between samples, and some contributing medical factors may be modifiable. However, no intervention guarantees improvement in sperm morphology or pregnancy outcomes.
6. Is IVF always more successful than IUI?
Not in every individual situation. Comparative benefits depend on the underlying infertility diagnosis, age, sperm quality, and other reproductive factors.
7. Is ICSI always better than conventional IVF?
No. ICSI may be valuable in significant male-factor infertility or selected fertilization problems, but routine ICSI does not consistently improve live-birth outcomes in couples without an appropriate indication.
8. Can treating varicocele eliminate the need for IVF?
In selected patients, varicocele treatment may improve semen parameters and reproductive outcomes. However, it does not guarantee natural conception or remove the need for assisted reproductive treatment.
9. Can herbal medicines cure male infertility?
There is insufficient reliable evidence to claim that herbal medicines universally cure male infertility. Treatment depends on the underlying diagnosis, and safety and effectiveness should be considered carefully.
10. Should men undergo fertility testing before IVF?
Yes. Assessment of male reproductive health is an essential component of a comprehensive fertility evaluation.
11. When should couples seek infertility evaluation?
Generally, couples should consider evaluation after 12 months of regular unprotected intercourse without conception. Earlier assessment is appropriate when the female partner is aged 35 years or older, known reproductive conditions exist, or other significant risk factors are present.
12. Should IVF be delayed to try other treatments?
Not necessarily. When IVF is medically indicated, delaying treatment may reduce the likelihood of success, particularly where female reproductive age or other time-sensitive factors are important.
Saira Health Care Continues Its Commitment to Reproductive Health Education
Infertility can affect emotional wellbeing, relationships, financial planning, and quality of life.
Accurate healthcare information helps couples understand their options and avoid decisions based entirely on fear, misconceptions, or unrealistic expectations.
Through educational videos, website articles, and awareness initiatives, Saira Health Care aims to make information about male infertility and reproductive healthcare more accessible.
The discussion "Watch This Before IVF" encourages couples to examine the complete medical picture before selecting fertility treatment.
It also addresses a frequently misunderstood issue: the clinical significance of abnormal sperm morphology.
By improving awareness about teratozoospermia, semen analysis, male reproductive conditions, and available fertility treatments, Saira Health Care hopes to support more informed and responsible healthcare decisions.
The message is not that IVF should be avoided. The message is that every couple deserves an accurate diagnosis, a clear explanation, and an appropriate treatment plan.
Watch Dr. Nizamuddin Qasmi's Educational Videos
For further understanding of IVF, male infertility, teratozoospermia, abnormal semen reports, reproductive disorders and related health topics, visit the official Saira Health Care YouTube channel.
Official YouTube Channel:
https://www.youtube.com/@SHCBBK
Subscribe and enable notifications to receive updates about new educational videos.
Connect With Saira Health Care
Official Saira Health Care Website
For information about sexual disorders, infertility, reproductive health and medical consultation:
https://sairahealthcare.com/
Saira Health Care Online Pharmacy
For medicine orders and information about available healthcare products:
https://pharmacy.sairahealthcare.com/
Medicines should be selected and used according to appropriate professional medical advice.
Subscribe to Our YouTube Channel
For educational videos and regular medical awareness updates:
https://www.youtube.com/@SHCBBK
Join Our Official WhatsApp Channel
Follow Saira Health Care for regular health news, educational updates and announcements:
https://whatsapp.com/channel/0029Vay4lGUHwXb2q0qI3t0W
Conclusion: Before IVF, Understand the Diagnosis and Make an Informed Decision
IVF has helped transform infertility treatment and remains an essential option for many couples.
However, reproductive treatment should not follow a one-size-fits-all approach.
Male infertility deserves proper attention. Teratozoospermia requires accurate interpretation. Semen analysis results must be evaluated as part of the complete reproductive picture.
Some couples may benefit from medical or surgical management of identified conditions, while others may require IUI, IVF, or ICSI.
The correct pathway depends on the circumstances of both partners and the available medical evidence.
Through "Watch This Before IVF," Dr. Nizamuddin Qasmi and Saira Health Care encourage couples to ask important questions, understand their reproductive health, and make informed decisions with appropriately qualified fertility professionals.
Before IVF, understand your diagnosis, understand your options, and understand why a particular treatment is recommended.
SAIRA HEALTH CARE
Dedicated to Sexual & Reproductive Health Awareness.
Medical References
- World Health Organization (WHO). WHO Laboratory Manual for the Examination and Processing of Human Semen, Sixth Edition, 2021.
https://www.who.int/publications/i/item/9789240030787 - National Institute for Health and Care Excellence (NICE). Fertility Problems: Assessment and Treatment, NG257, published 31 March 2026.
https://www.nice.org.uk/guidance/ng257 - American Urological Association / American Society for Reproductive Medicine (AUA/ASRM). Diagnosis and Treatment of Infertility in Men: Guideline.
https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility - European Association of Urology (EAU). Guidelines on Sexual and Reproductive Health – Male Infertility.
https://uroweb.org/guidelines/sexual-and-reproductive-health/chapter/male-infertility - American Society for Reproductive Medicine (ASRM). Intracytoplasmic Sperm Injection for Nonmale Factor Indications: Committee Opinion, 2026.
https://www.asrm.org/practice-guidance/practice-committee-documents/intracytoplasmic-sperm-injection-for-nonmale-factor-indications-a-committee-opinion-2026/
Medical Disclaimer
This article is intended solely for public education and general medical awareness. It is not a substitute for individualized medical consultation, infertility diagnosis, or treatment. The appropriateness of IVF, ICSI, IUI, medicines, surgery, or other interventions depends on the clinical findings and reproductive circumstances of each couple. Treatment decisions should be made in consultation with appropriately qualified reproductive healthcare specialists. Couples should not delay medically indicated fertility treatment on the basis of this article.